Phase I clinical trial of peptide vaccine derived from HSP105 and analysis of immune response in vaccinated patients

被引：0
|
作者：
Shimizu, Yasuhiro [1 ]
Yoshikawa, Toshiaki [1 ]
Syoda, Kayoko [1 ]
Nosaka, Kazuto [1 ]
Shimomura, Manami [1 ]
Mizuno, Shoichi [1 ]
Wada, Satoshi [2 ]
Fujimoto, Yuki [2 ]
Kohashi, Kenichi [3 ]
Kojima, Takashi [4 ]
Endo, Itaru [5 ]
Nakatsura, Tetsuya [1 ]
机构：
[1] EPOC, Natl Canc Ctr, Div Canc Immunother, Tokyo, Japan
[2] Kanagawa Canc Ctr, Res Inst, Dept Canc Immunother, Yokohama, Kanagawa, Japan
[3] Kyushu Univ, Grad Sch Med, Dept Anat Path Pathol Sci, Fukuoka, Fukuoka, Japan
[4] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan
[5] Yokohama City Univ, Grad Sch Med, Dept Gastroenterol Surg, Yokohama, Kanagawa, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3206
引用
收藏
页码：1334 / 1334
页数：1
相关论文
共 50 条
  • [1] Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial
    Shimizu, Yasuhiro
    Yoshikawa, Toshiaki
    Kojima, Takashi
    Shoda, Kayoko
    Nosaka, Kazuto
    Mizuno, Shoichi
    Wada, Satoshi
    Fujimoto, Yuki
    Sasada, Tetsuro
    Kohashi, Kenichi
    Bando, Hideaki
    Endo, Itaru
    Nakatsura, Tetsuya
    [J]. CANCER SCIENCE, 2019, 110 (10) : 3049 - 3060
  • [2] Immune response to vaccination with DNA-hsp65 in a phase I clinical trial with head and neck cancer patients
    G D Victora
    A Socorro-Silva
    E C Volsi
    K Abdallah
    F D Lima
    R B Smith
    R A Moyses
    C R Zárate-Bladés
    P Michaluart
    C L Silva
    J Kalil
    V Coelho
    [J]. Cancer Gene Therapy, 2009, 16 : 598 - 608
  • [3] Immune response to vaccination with DNA-hsp65 in a phase I clinical trial with head and neck cancer patients
    Victora, G. D.
    Socorro-Silva, A.
    Volsi, E. C.
    Abdallah, K.
    Lima, F. D.
    Smith, R. B.
    Moyses, R. A.
    Zarate-Blades, C. R.
    Michaluart, P.
    Silva, C. L.
    Kalil, J.
    Coelho, V.
    [J]. CANCER GENE THERAPY, 2009, 16 (07) : 598 - 608
  • [4] Phase I clinical trial of survivin-derived peptide vaccine therapy for patients with advanced or recurrent oral cancer
    Miyazaki, Akihiro
    Kobayashi, Junichi
    Torigoe, Toshihiko
    Hirohashi, Yoshihiko
    Yamamoto, Takashi
    Yamaguchi, Akira
    Asanuma, Hiroko
    Takahashi, Akari
    Michifuri, Yoshitaka
    Nakamori, Kenji
    Nagai, Itaru
    Sato, Noriyuki
    Hiratsuka, Hiroyoshi
    [J]. CANCER SCIENCE, 2011, 102 (02) : 324 - 329
  • [5] Immune correlates of survival in advanced hepatocellular carcinoma patients treated with glypican-3-derived peptide vaccine: Results from phase I trial
    Sawada, Yu
    Nobuoka, Daisuke
    Yoshikawa, Toshiaki
    Shimomura, Manami
    Saito, Keigo
    Mizuno, Shoichi
    Nakatsura, Tetsuya
    [J]. CANCER RESEARCH, 2012, 72
  • [6] Phase 1 study of HSP105-derived peptide vaccine for patients with advanced esophageal cancer/colo-rectal cancer
    Wada, S.
    Kojima, T.
    Nakatsura, T.
    Bando, H.
    Motohashi, O.
    Shimomura, M.
    Yoshikawa, T.
    Kohashi, K.
    Hori, A.
    Ono, H.
    Fukutani, M.
    Wakabayashi, M.
    Nomura, S.
    Sato, A.
    Sasada, T.
    Ohtsu, A.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [7] Phase I Clinical Trial of Glypican-3 Peptide Vaccine in Patients with Hepatocellular Carcinoma
    Nakatsura, Tetsuya
    Yoshikawa, Toshiaki
    Kuronuma, Toshimitsu
    Shirakawa, Hirofumi
    Hayashi, Emiko
    Nishimura, Yoshiko
    Tsuchihara, Masami
    Motomura, Yutaka
    [J]. TUMOR BIOLOGY, 2008, 29 : 22 - 22
  • [8] A phase I trial of a synthetic mucin peptide vaccine induction of specific immune reactivity in patients with adenocarcinoma
    Goydos, JS
    Elder, E
    Whiteside, TL
    Finn, OJ
    Lotze, MT
    [J]. JOURNAL OF SURGICAL RESEARCH, 1996, 63 (01) : 298 - 304
  • [9] Clinical and immunologic responses of HLA-A3+ breast cancer patients vaccinated with the HER2/neu-derived peptide vaccine, E75, in a phase I clinical trial.
    Paul, R.
    Holmes, J. P.
    Amin, A.
    Carmichael, M.
    Jama, Y. H.
    McNeill, A.
    Hueman, M. T.
    Craig, D.
    Ponniah, S.
    Peoples, G. E.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S123 - S124
  • [10] Clinical and Immunologic Responses of HLA-A3+ Breast Cancer Patients Vaccinated with the HER2/neu-Derived Peptide Vaccine, E75, in a Phase I/II Clinical Trial
    Patil, Ritesh
    Clifton, Guy T.
    Holmes, Jarrod P.
    Amin, Asna
    Carmichael, Mark G.
    Gates, Jeremy D.
    Benavides, Linda H.
    Hueman, Matthew T.
    Ponniah, Sathibalan
    Peoples, George E.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 210 (02) : 140 - 147
12345